Mixed depressive features predict maniform switch during treatment of depression in bipolar I disorder

被引:76
作者
Bottlender, R [1 ]
Sato, T [1 ]
Kleindienst, N [1 ]
Strauss, A [1 ]
Möller, HJ [1 ]
机构
[1] Univ Munich, Psychiat Klin, Dept Psychiat, D-80336 Munich, Germany
关键词
bipolar I depression; maniform switches; mixed depression;
D O I
10.1016/S0165-0327(02)00265-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Case observations imply that depressed patients with mixed features are of high risk for maniform switch during acute treatment. Methods: The medical records of 158 bipolar I depressives were examined with respect to mixed depressive features at admission, naturalistic medications, and maniform switch during inpatient treatment. Results: Besides pharmacological variables, the number of mixed depressive symptoms (flight of ideas, racing thoughts, logorrhea, aggression, excessive social contact, increased drive, irritability, and distractibility) at admission was associated with a higher risk for, and the acceleration of, maniform switch during inpatient treatment. Limitations: This was a retrospective study in patients receiving naturalistic treatment. The cohort was hospital based and thus not representative of the full range of bipolar affective disorder. Conclusions: In line with recent studies, our results underline the factors inherent in subjects at a higher risk of switch. Investigation of the relationships between several inherent factors and their interactions with pharmacological treatments may be important in resolving the controversy surrounding antidepressant-induced mania. Further validation studies on mixed depression are warranted. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:149 / 152
页数:4
相关论文
共 16 条
[11]   The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder - Preliminary findings [J].
Mundo, E ;
Walker, M ;
Cate, T ;
Macciardi, F ;
Kennedy, JL .
ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (06) :539-544
[12]   INDUCTION OF MANIA WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND TRICYCLIC ANTIDEPRESSANTS [J].
PEET, M .
BRITISH JOURNAL OF PSYCHIATRY, 1994, 164 :549-550
[13]  
PIETZCKER A, 1983, AMDP SYSTEM PHARMACO, P88
[14]  
Renfordt E, 1983, Mod Probl Pharmacopsychiatry, V20, P125
[15]  
Rouillon F, 1992, LONG TERM TREATMENT
[16]  
SATO T, 2002, IN PRESS J AFFECT DI